Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 2049-2056

  Kao, Yeh Chih ^a   Okubo, Tomoharu ^a   Sun, Xiu Zhu ^a   Chen, Shiuan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aminoglutethimide; Aromatase inhibitor; Breast cancer

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; AMINOGLUTETHIMIDE; AROMATASE; AROMATASE INHIBITOR; BETA ACTIN; CYCLIC AMP; CYTOCHROME P450; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA TRANSFECTION; DOSE RESPONSE; ENZYME INDUCTION; GENE INDUCTION; HUMAN; HUMAN CELL; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

ADENINE; ADENOCARCINOMA; ADENYLATE CYCLASE; AMINOGLUTETHIMIDE; ANIMALS; ANTINEOPLASTIC AGENTS; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHO CELLS; CHORIOCARCINOMA; CRICETINAE; CRICETULUS; CYCLIC AMP; DRUG RESISTANCE, NEOPLASM; ENZYME INDUCTION; ENZYME INHIBITORS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA, NEOPLASM; SECOND MESSENGER SYSTEMS; TRANSCRIPTION, GENETIC; TREATMENT FAILURE; UTERINE NEOPLASMS;

EID: 0032799879     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lippman ME, Dickson RB, Kasid A, Gelmann E, Davidson N, McManaway M, Huff K, Bronzert D, Bates S, Swain S, et al: Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem 24: 147-154, 1986.
2. Bates SE, Davidson NE, Valverius EM, Freter CE, Dickson RB, Tam JP, Kudlow JE, Lippman ME, and Salomon DS: Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. M Endocrinoh 2: 543-555, 1988.
3. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, and Simpson ER: Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53: 412-417, 1981.
4. Santen RJ, Samojlik E, and Wells SA: Resistance of the ovary to blockade of aromatization with aminoglutethimide. J Clin Endocrinol Metab 51: 473-477, 1980.
5. Coombes RC, Goss PE, Dowsett M, Hutchinson G, Cunningham D, Jarman M, and Brodie AMH: 4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer. Steroids, 50: 245-252, 1987.
6. Miller WR, and O'Neill J: The importance of local synthesis of estrogen within the breast. Steroids 50: 537-548, 1987.
7. Dexter RN, Fishman LM, Ney RL, and Liddle GW: Inhibition of adrenal corticosteroid synthesis by aminoglytethimide: studies of the mechanism of action. J Clin Endocrinol Metab 27: 473, 1987.
8. Kitawaki J, Kim T, Kanno H, Noguchi T, Yamamoto T, and Okada H: Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: A new system for aromatase inhibitor screening. J Steroid Biochem Molec Biol 44: 667-670, 1993.
9. Yue W and Brodie AMH: Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture. J Steroid Biochem Molec Biol 63: 317-328, 1997.
10. Harada N and Hatano O: Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumor cells. Br J Cancer 77: 567-572, 1998.
11. Zhou D, Pompon D, and Chen S: Stable expression of human aromatase cDNA in mammalian cells. A useful system for aromatase inhibitor screening. Cancer Res 50: 6949-6954, 1990.
12. Sun XZ, Zhou D, and Chen S: Autocrine and paracrine actions of breast tumo: aromatase. A three-dimensional cell culture study-involving aromatase transfected MCF-7 andT-47D cells. J Steroid Biochem Mol Biol 63: 29-36, 1997.
13. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
14. Thompson EA, Jr. and Siiteri PK: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249: 5364-5372, 1974.
15. Yoshida N and Osawa Y: Purification of human placental aromatase cytochrome P-450 with monoclonal antibody and its characterization. Biochemistry 30: 3003-3010, 1991.
16. Kao YC, Cam LL, Laughton CA, Zhou D, and Chen S: Binding characteristics of seven aromatase inhibitors to human aromatase. A site-directed mutagenesis study. Cancer Res 56: 3451-3460, 1996.
17. Harada N: A unique aromatase (P-450arom) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem Biophys Res Commun 189: 1001-1007, 1993.
18. Mahendroo MS, Mendelson CR, and Simpson, ER: Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 268: 19463-19470, 1993.
19. Esteban JM, Warsi Z, Haniu M, Hall PF, Shively JE, and Chen S: Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinico-pathologic correlation. J Amer Pathol 140: 337-343, 1992.
20. Zhou C, Zhou D, Esteban J, Murai J, Sitteri PI, Wilczynski S, and Chen S: Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR). J Steroid Biochem and Mol Biol 59: 163-171, 1996.
21. Gilliland G, Perrin S, Blanchard K, and Bunn HF: Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87: 2725-2729, 1990.
22. Reed MJ, Owen AM, Lai LC, Coldham NG, Ghilchik MW, Shaikh NA, and James VHT: In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44: 233-237, 1989.
23. Wang J, and Chen S: Induction of aromatase gene expression in human placental choriocarcinoma (JAR) cells by phorbol esters. Biochim Biophys Acta 1218: 48-54, 1994.